Excelsior Correspondent
SRINAGAR, Apr 10: High Court has directed the Jammu and Kashmir Medical Supplies Corporation Ltd to file an affidavit indicating therein the supply of life saving drugs provided to Government Medical College (GMC) Srinagar for the financial year 2025-26.
The Division Bench of Chief Justice Arun Palli and Justice Rajnesh Oswal sought information from the Corporation with regard to supply of drugs to GMC Srinagar for the financial year within a period of three weeks.
The counsel for the petitioner-advocate Iman Muiz submitted before the court that the compliance report in terms of previous court orders have been filed by the authorities and he intends to file an additional affidavit in response to the compliance report. The court allowed his prayer.
The PIL has been filed with the prayer to direct the authorities to immediately ensure uninterrupted availability and supply of anti-haemophilic drugs and such other essential clotting factor concentrates to GMC, Srinagar and all other designated treatment centers across the Jammu and Kashmir
It is further sought that a direction for release, without any further delay, the entire quantity of antihemophilic drugs lying stocked with JKMSCL to the concerned hospitals, in furtherance of the annual and supplementary requisitions already raised.
The counsel appearing in the PIL submitted that the grievance as projected in the PIL is classified as of two fold one is total non-availability of Anti-Hemophilic drugs in the hospitals of J&K at the moment despite requisitions, approvals, and sanction of budget and second is chronic and systemic issues of delayed, insufficient and irregular requisition, procurement, supply and release of Anti-Hemophilic drugs to hospitals in J&K.
In this regard a communication on 12.02.2025 came to be issued by the Head of Pathology, GMC Srinagar, to the Principal GMC Srinagar whereby a list of required anti-hemophilic drugs in the form of an annual demand Filed through totaling to about Rs. 31.91 Crores has been forwarded.
The demand, despite a huge delay and lapse of time, is yet to be released to the hospitals. Besides this, both advocates highlighted the chronic and systemic issues of delayed, insufficient and irregular requisition, procurement, supply and release of anti-haemophilic putting the lives of hemophilic patients at peril.
Follow our WhatsApp channel
